These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37678548)

  • 1. Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
    Guy A; Garcia G; Gourdou-Latyszenok V; Wolff-Trombini L; Josserand L; Kimmerlin Q; Favre S; Kilani B; Marty C; Boulaftali Y; Labrouche-Colomer S; Mansier O; James C
    J Thromb Haemost; 2024 Jan; 22(1):172-187. PubMed ID: 37678548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.
    Wolach O; Sellar RS; Martinod K; Cherpokova D; McConkey M; Chappell RJ; Silver AJ; Adams D; Castellano CA; Schneider RK; Padera RF; DeAngelo DJ; Wadleigh M; Steensma DP; Galinsky I; Stone RM; Genovese G; McCarroll SA; Iliadou B; Hultman C; Neuberg D; Mullally A; Wagner DD; Ebert BL
    Sci Transl Med; 2018 Apr; 10(436):. PubMed ID: 29643232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia.
    Haage TR; Charakopoulos E; Bhuria V; Baldauf CK; Korthals M; Handschuh J; Müller P; Li J; Harit K; Nishanth G; Frey S; Böttcher M; Fischer KD; Dudeck J; Dudeck A; Lipka DB; Schraven B; Green AR; Müller AJ; Mougiakakos D; Fischer T
    J Hematol Oncol; 2024 Jun; 17(1):43. PubMed ID: 38853260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency.
    Dou H; Kotini A; Liu W; Fidler T; Endo-Umeda K; Sun X; Olszewska M; Xiao T; Abramowicz S; Yalcinkaya M; Hardaway B; Tsimikas S; Que X; Bick A; Emdin C; Natarajan P; Papapetrou EP; Witztum JL; Wang N; Tall AR
    Circulation; 2021 Dec; 144(24):1940-1954. PubMed ID: 34846914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis.
    Martinod K; Witsch T; Farley K; Gallant M; Remold-O'Donnell E; Wagner DD
    J Thromb Haemost; 2016 Mar; 14(3):551-8. PubMed ID: 26712312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.
    Sun T; Zhang L
    Clin Appl Thromb Hemost; 2013; 19(4):374-81. PubMed ID: 22826442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells induce neutrophil extracellular trap formation in venous thrombosis.
    Bertin FR; Rys RN; Mathieu C; Laurance S; Lemarié CA; Blostein MD
    J Thromb Haemost; 2019 Feb; 17(2):403-414. PubMed ID: 30456926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK2V617F-dependent down regulation of SHP-1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF-β.
    Aoun C; Maslah N; Ganesan S; Salomao N; Gendron R; Awan Toor S; Letort G; Gou P; Bonnamy M; Parietti V; Kiladjian JJ; Giraudier S; Cassinat B
    J Cell Mol Med; 2024 Oct; 28(20):e70138. PubMed ID: 39431551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events.
    Schmidt S; Daniliants D; Hiller E; Gunsilius E; Wolf D; Feistritzer C
    Blood Adv; 2021 Sep; 5(18):3515-3527. PubMed ID: 34464975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic force triggers rapid NETosis within sterile thrombotic occlusions.
    Yu X; Tan J; Diamond SL
    J Thromb Haemost; 2018 Feb; 16(2):316-329. PubMed ID: 29156107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.
    Castiglione M; Jiang YP; Mazzeo C; Lee S; Chen JS; Kaushansky K; Yin W; Lin RZ; Zheng H; Zhan H
    J Thromb Haemost; 2020 Dec; 18(12):3359-3370. PubMed ID: 32920974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombosis among 1537 patients with JAK2
    Zhang Y; Zhou Y; Wang Y; Teng G; Li D; Wang Y; Du C; Chen Y; Zhang H; Li Y; Fu L; Chen K; Bai J
    Cancer Med; 2020 Mar; 9(6):2096-2105. PubMed ID: 31994332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm.
    Lamrani L; Lacout C; Ollivier V; Denis CV; Gardiner E; Ho Tin Noe B; Vainchenker W; Villeval JL; Jandrot-Perrus M
    Blood; 2014 Aug; 124(7):1136-45. PubMed ID: 24951423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells.
    Mansier O; Kilani B; Guitart AV; Guy A; Gourdou-Latyszenok V; Marty C; Parrens M; Plo I; Vainchenker W; James C
    Blood; 2019 Dec; 134(26):2383-2387. PubMed ID: 31697834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.
    Yang Y; Abbas S; Sayem MA; Dutta A; Mohi G
    Blood Cancer J; 2023 Nov; 13(1):171. PubMed ID: 38012156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils.
    Kimishima Y; Misaka T; Yokokawa T; Wada K; Ueda K; Sugimoto K; Minakawa K; Nakazato K; Ishida T; Oshima M; Koide S; Shide K; Shimoda K; Iwama A; Ikeda K; Takeishi Y
    Nat Commun; 2021 Oct; 12(1):6177. PubMed ID: 34702814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clonal hematopoiesis mutation Jak2
    Molinaro R; Sellar RS; Vromman A; Sausen G; Folco E; Sukhova GK; McConke ME; Corbo C; Ebert BL; Libby P
    Int J Cardiol; 2024 Aug; 409():132184. PubMed ID: 38759798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice.
    Akada H; Akada S; Hutchison RE; Mohi G
    Leukemia; 2014 Aug; 28(8):1627-35. PubMed ID: 24480985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.
    Zhao B; Mei Y; Cao L; Zhang J; Sumagin R; Yang J; Gao J; Schipma MJ; Wang Y; Thorsheim C; Zhao L; Stalker T; Stein B; Wen QJ; Crispino JD; Abrams CS; Ji P
    J Clin Invest; 2018 Jan; 128(1):125-140. PubMed ID: 29202466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alpha-2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms.
    Massarenti L; Knudsen TA; Enevold C; Skov V; Kjaer L; Larsen MK; Larsen TS; Hansen DL; Hasselbalch HC; Nielsen CH
    Br J Haematol; 2023 Jul; 202(2):318-327. PubMed ID: 37211985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.